Materias dentro de su búsqueda.
Mostrando 2,541 - 2,560 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 0.37s Limitar resultados
  1. 2541
    “…Pancreatic cancer has a poor prognosis. New treatment options are urgently required to improve patient outcomes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells
  2. 2542
    “…We conclude that resveratrol acts as an effective antioxidant in reversing the nicotine induced pancreatic cancer cell proliferation.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effects of a natural polyphenol on nicotine-induced pancreatic cancer cell proliferation
  3. 2543
    “…Locally advanced pancreatic cancer (LAPC) has several definitions but essentially is a nonmetastasized pancreatic cancer, in which upfront resection is considered not beneficial due to extensive vascular involvement and consequent high chance of a nonradical resection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Locally Advanced Pancreatic Cancer: Work-Up, Staging, and Local Intervention Strategies
  4. 2544
    “…Here we review the literature on surgical and locoregional approaches including radiofrequency ablation, irreversible electroporation, and stereotactic body radiation, and focus on patients with hepatic oligometastatic pancreatic cancer. We provide a summary regarding survival outcomes, morbidity and mortality and discuss selection criteria that may be useful to predict the best outcomes for such strategies.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?
  5. 2545
    “…Pancreatic cancer represents a major challenge in oncology. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Electrochemotherapy Causes Caspase-Independent Necrotic-Like Death in Pancreatic Cancer Cells
  6. 2546
    “…This study included 82 localized pancreatic cancer, 40 of whom were treated with neoadjuvant therapy (NAT) using four courses of gemcitabine plus nab-paclitaxel (GnP) followed by pancreatectomy (GnP group). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Encapsulating fibrosis following neoadjuvant chemotherapy is correlated with outcomes in patients with pancreatic cancer
  7. 2547
    “…Developing new targeted therapy for pancreatic cancer is one of the major current challenges in cancer research. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer
  8. 2548
    “…Our previous study reported the safety and efficacy of EUS-guided fine-needle injection (EUS-FNI) of STNM01, a double-stranded RNA oligonucleotide that specifically represses CHST15, for use in patients with pancreatic cancer. The present study aimed to determine the expression and clinicopathological characteristics of CHST15 in pancreatic cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Overexpression of carbohydrate sulfotransferase 15 in pancreatic cancer stroma is associated with worse prognosis
  9. 2549
    por Karamitopoulou, Eva
    Publicado 2019
    “…Pancreatic cancer is a lethal disease, with fewer than 7% of patients surviving beyond 5 years following diagnosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features
  10. 2550
    “…BACKGROUND: Previous studies revealed somatic mutations of the cationic trypsinogen gene (PRSS1) in patients with chronic pancreatitis and pancreatic cancer. However, whether PRSS1 mutations trigger pancreatic cancer and/or promote malignant proliferation and metastasis in pancreatic cancer remains largely unclear, as well as the potential underlying mechanisms. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PRSS1 mutation: a possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer
  11. 2551
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary
  12. 2552
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Interleukin 21 Receptor/Ligand Interaction Is Linked to Disease Progression in Pancreatic Cancer
  13. 2553
    “…Inhibition of the Hh signaling pathway is a potential therapeutic target for pancreatic cancer. The aim of the present study was to investigate the effects of dauricine in a pancreatic cancer BxPC-3 ×enograft animal model and examine the underlying molecular mechanisms through Hh signaling pathway. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Dauricine suppresses the growth of pancreatic cancer in vivo by modulating the Hedgehog signaling pathway
  14. 2554
    “…Approximately 25% of patients diagnosed with pancreatic cancer present with non-metastatic resectable or borderline resectable disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons
  15. 2555
    “…The Nim-nano exhibited sustained release of Nim for more than 6 days in PBS (pH 7.4) and showed two- to three-fold enhanced cytotoxicity in breast and pancreatic cancer cell lines compared with free Nim. CONCLUSION: The Nim-nano formulation has great potential for treatment of cancers, such as pancreatic and breast cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Nanodelivery and anticancer effect of a limonoid, nimbolide, in breast and pancreatic cancer cells
  16. 2556
    “…BACKGROUND: Pancreatic cancer (PC) is an aggressive disease with a dismal 5-year survival rate. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program
  17. 2557
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy
  18. 2558
    “…BACKGROUND: Pancreatic cancer is one of the most lethal malignancies due to frequent late diagnosis, aggressive tumor growth and metastasis formation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Attenuation of hedgehog/GLI signaling by NT1721 extends survival in pancreatic cancer
  19. 2559
    “…Overall survival in a phase III study for metastatic pancreatic cancer has significantly improved with gemcitabine (GEM) plus nab-paclitaxel. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer
  20. 2560
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
Herramientas de búsqueda: RSS